Stock-Based Compensation for DaVita (DVA)
Stock-Based Compensation for DaVita (DVA): headline value $101.56M · YoY +36.2%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
DVA
Currently viewingStock-Based CompensationSwitch metric
Latest period
$101.56M
YoY change
+36.2%
5Y CAGR
+8.9%
Peak year (2025)
$139.95M
Latest annual
$139.95M
Stock-Based Compensation history chart for DaVita (DVA) from 1994 to 2025
Stock-Based Compensation history table for DaVita (DVA) from 1994 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $139.95M | +36.2% | ||
| 2024 | $102.79M | -8.5% | ||
| 2023 | $112.38M | +17.8% | ||
| 2022 | $95.43M | -6.6% | ||
| 2021 | $102.21M | +11.8% | ||
| 2020 | $91.46M | +34.8% | ||
| 2019 | $67.85M | -7.1% | ||
| 2018 | $73.06M | +108.2% | ||
| 2017 | $35.09M | -8.5% | ||
| 2016 | $38.34M | -32.3% | ||
| 2015 | $56.66M | +3.1% | ||
| 2014 | $54.97M | -8.4% | ||
| 2013 | $60.00M | +32.2% | ||
| 2012 | $45.38M | -6.8% | ||
| 2011 | $48.72M | +7.0% | ||
| 2010 | $45.55M | +2.5% | ||
| 2009 | $44.42M | +7.7% | ||
| 2008 | $41.23M | +20.8% | ||
| 2007 | $34.15M | +29.4% | ||
| 2006 | $26.39M | +21.8% | ||
| 2005 | $21.66M | +272.2% | ||
| 2004 | $5.82M | 0.0% | ||
| 2003 | $5.82M | -14.9% | ||
| 2002 | $6.84M | -62.0% | ||
| 2001 | $17.99M | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — |
Stock-Based Compensation values are taken from DaVita's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, DaVita (DVA) reported stock-based compensation of $139.95M – surged 36.2% year-over-year.
Looking at the 2020–2025 (5 years) stretch, DaVita stock-based compensation compounded at +8.9% per year, with the latest reading among the more recent periods of the dataset.
Across the available history, stock-based compensation reached its high of $139.95M in 2025 and its low of $0 in 1994.
Within Healthcare, DaVita (DVA) ranks 5th among 8 peers we track. The peer median for stock-based compensation is $313.00M.
DaVita Stock-Based Compensation by Year
DaVita Stock-Based Compensation 2025: $139.95M
DaVita stock-based compensation in 2025 was $139.95M, surged 36.2% from 2024. This figure represents the highest annual value in the available history.
DaVita Stock-Based Compensation 2024: $102.79M
DaVita stock-based compensation in 2024 was $102.79M, declined 8.5% below 2023.
DaVita Stock-Based Compensation 2023: $112.38M
DaVita stock-based compensation in 2023 was $112.38M, grew 17.8% from 2022.
DaVita Stock-Based Compensation 2022: $95.43M
DaVita stock-based compensation in 2022 was $95.43M, declined 6.6% below 2021.
DaVita Stock-Based Compensation 2021: $102.21M
DaVita stock-based compensation in 2021 was $102.21M.
See more financial history for DaVita (DVA).
Sector peers — Stock-Based Compensation
Companies in the same sector as DaVita, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is DaVita's stock-based compensation?
Latest reported stock-based compensation for DaVita (DVA) is $101.56M (period ending December 31, 2025).
How has DaVita stock-based compensation changed year-over-year?
DaVita (DVA) stock-based compensation changed +36.2% year-over-year on the latest annual filing.
What is the long-term growth rate of DaVita stock-based compensation?
DaVita (DVA) stock-based compensation compound annual growth rate is +8.9% over the most recent 5 years available.
When did DaVita stock-based compensation hit its highest annual value?
DaVita stock-based compensation reached its highest annual value of $139.95M in 2025.
What was DaVita stock-based compensation in 2024?
DaVita (DVA) stock-based compensation in 2024 was $102.79M.
What was DaVita stock-based compensation in 2025?
DaVita (DVA) stock-based compensation in 2025 was $139.95M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
DVA Overview
Company profile, financial tools, and key metrics
DVA Revenue Counter
Earns $432.62 every second. See per minute, hour, and day.
DVA Earnings Counter
Earns $23.68 per second net profit. See per minute, hour, and day.
DVA Economic Scale
Exceeds Namibia's GDP. Compare with world economies.
DVA What If Invested
What if you had invested $1,000? See historical returns from any date.
DVA How It Makes Money
Discover visual breakdown of $13.64B in revenue — where it comes from and where it goes.
DVA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DVA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DVA Daily Price Character
Balanced · 50.5% historical win rate (green days). Streaks & record days.
DVA Buybacks
18.33% TTM buyback yield. Shareholder yield & SBC comparison.
DVA Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.